Science to Practice: Monitoring Oncolytic Virus Therapy with Chemical Exchange Saturation Transfer MR Imaging--Wishful Thinking?

Area of Science:

• Oncology
• Biomedical Imaging
• Virology

Background:

• Oncolytic viruses (OVs) are engineered viruses that selectively infect and kill cancer cells.
• Current OV therapies are improving in specificity and efficacy.
• Monitoring OV delivery and activity within tumors remains a challenge.

Purpose of the Study:

• To investigate if modified OVs producing excess proteins can be detected non-invasively.
• To establish a method for early detection of OV infection in cancer cells using advanced imaging techniques.

Main Methods:

• Modification of an oncolytic virus to overexpress proteins upon cancer cell infection.
• Utilizing chemical exchange saturation transfer (CEST) magnetic resonance (MR) imaging to detect the protein overexpression.
• In vitro and in vivo experiments in infected cancer cells.

Main Results:

• Demonstrated detection of the excess protein production in infected cancer cells using CEST MR imaging.
• The detectable effect was approximately 1%, at the limits of current MR imaging sensitivity.
• Successful detection was achieved both in vitro and in vivo.

Conclusions:

• Modified OVs can be visualized through their protein production using CEST MR imaging.
• This technique offers a novel approach for early detection of OV delivery and activity in tumors.
• This represents a significant advancement in translating OV therapy from the lab to clinical application.